AbCellera Biologics Inc. (ABCL) vs Regencell Bioscience Holdings Limited (RGC)
A side-by-side comparison of AbCellera Biologics Inc. and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.18HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
RGC
Regencell Bioscience Holdings Limited
$7.58HealthcareDelayed quote: Oct 6, 2026, 1:39 PM EDT
Total return — ABCL vs RGC
growth of $100 · dividends reinvested · last 5yABCL -18.6% (-4.0%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
ABCL RGC
ABCL vs RGC: by the numbers
- •ABCL is the larger company ($4.02B vs $3.76B market cap).
- •Both run net losses; RGC's is the smaller (0.00% vs -248.83% net margin).
Metrics side by side
Valuation
| Metric | ABCL | RGC |
|---|---|---|
| P/S ratio | 60.82 | N/A |
| P/B ratio | 4.49 | 3079.99 |
Profitability
| Metric | ABCL | RGC |
|---|---|---|
| Gross margin | 61.64% | 0.00% |
| Operating margin | -288.98% | 0.00% |
| Net margin | -248.83% | 0.00% |
| ROE | -18.38% | -73.75% |
| ROIC | -17.95% | -69.75% |
Growth (annualized)
| Metric | ABCL | RGC |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | N/A |
| Total return CAGR (5Y) | -3.57% | 67.94% |
Frequently asked
- How have ABCL and RGC total returns compared?
- Over the past 5 years, ABCL delivered -3.57% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.